COMMUNIQUÉS West-GlobeNewswire

ThromboGenics Initiates Phase 2 Clinical Study Evaluating anti-PlGF (THR-317) in combination with anti-VEGF (ranibizumab) for treatment of Diabetic Macular Edema (DME)
27/04/2018
Press release Leuven, Belgium, April 27 2018 - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel medicines for diabetic eye disease, announces that it has successfully enrolled the [...]
Basilea announces appointment of Chief Technology Officer and appointment of Head of Global Quality Management
27/04/2018
Dr. Gerrit Hauck appointed as Chief Technology Officer, succeeding Dr. Günter Ditzinger who will take on new responsibilities at Basilea Dr. Anne Stehlin succeeding Dr. Josef Künzle as Head of Global Quality Management [...]
TiGenix: Publication of prospectus and response memorandum for Takeda takeover bid commencing on April 30, 2018
27/04/2018
PRESS RELEASE Publication of prospectus and response memorandum for Takeda takeover bid commencing on April 30, 2018 Leuven (BELGIUM) - April 27, 2018, 07:00h CEST - TiGenix NV (Euronext Brussels and NASDAQ: TIG) (" [...]
TiGenix: Publication du prospectus et mémoire en réponse pour l'offre publique d'acquisition de Takeda débutant le 30 avril 2018
27/04/2018
COMMUNIQUÉ DE PRESSE Publication du prospectus et mémoire en réponse pour l'offre publique d'acquisition de Takeda débutant le 30 avril 2018 Louvain (Belgique) - 27 avril 2018, 7:00h CEST - TiGenix NV (Euronext [...]
Essilor - News Release: First Quarter Driving Toward Full-Year Targets
27/04/2018
First Quarter Driving Toward Full-Year Targets PDF Version of the news release Sustained momentum in China and return to growth in Brazil Solid trends in mature countries impacted by poor weather Good results in sunwear [...]
Essilor - Communiqué : Premier trimestre en ligne avec l'objectif annuel
27/04/2018
Premier trimestre en ligne avec l'objectif annuel Version PDF du communiqué Dynamique soutenue en Chine et retour à la croissance au Brésil Activité solide dans les pays matures mais conditions climatiques défavorables [...]
MediciNova Announces Additional Data from Completed Clinical Trial of MN-166 (ibudilast) in ALS Presented at the American Academy of Neurology (AAN) 70th Annual Meeting
27/04/2018
LA JOLLA, Calif., April 26, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875 [...]
Marrone Bio Innovations Announces Exercise of Over-Allotment Option in Public Offering of Common Stock
26/04/2018
DAVIS, Calif., April 26, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI or the “Company”), a leading provider of bio-based pest management and plant health products for the agriculture, turf [...]
Le Groupe Jean Coutu – Dividende Spécial
26/04/2018
VARENNES, Québec, 26 avr. 2018 (GLOBE NEWSWIRE) -- Le Groupe Jean Coutu (PJC) inc. (la « Société » ou le « Groupe Jean Coutu ») (TSX:PJC.A) annonce que son conseil d’administration a déclaré aujourd’hui un dividende de [...]
The Jean Coutu Group – Special Dividend
26/04/2018
VARENNES, Quebec, April 26, 2018 (GLOBE NEWSWIRE) -- The Jean Coutu Group (PJC) inc. (the "Corporation" or the "Jean Coutu Group") (TSX:PJC.A) announces that its Board of Directors has declared today a dividend of $0. [...]
Integra LifeSciences to Present at Healthcare Conference in May 2018
26/04/2018
PLAINSBORO, N.J., April 26, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART ), a leading global medical technology company, will present at the following healthcare conferences in May: [...]
AIT Therapeutics Receives Patent Allowance for Delivery of Inhaled Nitric Oxide at Concentrations of at Least 160ppm for Treatment of Bronchiolitis in Infants
26/04/2018
Bronchiolitis is primarily caused by respiratory syncytial virus (RSV) NEW YORK, April 26, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTC:AITB), a clinical-stage medical device and biopharmaceutical company [...]
Adamas to Announce First Quarter 2018 Financial Results and Host Conference Call on May 3, 2018
26/04/2018
EMERYVILLE, Calif., April 26, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced that the company will report first quarter 2018 financial results on Thursday, May 3, 2018, after [...]
Vital Therapies Announces Upcoming First Quarter Financial Results Conference Call with Webcast
26/04/2018
SAN DIEGO, April 26, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL ), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, will release [...]
Vical Announces News Release and Conference Call Schedule for First Quarter 2018 Financial Results
26/04/2018
SAN DIEGO, April 26, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq: VICL ) today announced that the company will report financial results for the three months ended March 31, 2018, before the opening of trading on [...]
Chembio Diagnostics to Report First Quarter 2018 Financial Results on May 9, 2018
26/04/2018
MEDFORD, N.Y., April 26, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI ), a leader in point-of-care diagnostic tests for infectious diseases, announced today that it will release financial results for [...]
Akcea Therapeutics Announces Presentations on Volanesorsen and FCS at the National Lipid Association Scientific Sessions
26/04/2018
Results to be presented show significant reduction in triglyceride levels associated with reductions of pancreatitis and burden of disease in patients with FCS CAMBRIDGE, Mass. and LAS VEGAS, April 26, 2018 (GLOBE [...]
TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
26/04/2018
REGULATED INFORMATION PRESS RELEASE Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - April 26, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") [...]
athenahealth Reports First Quarter Fiscal Year 2018 Results
26/04/2018
Company Achieves Double Digit Revenue Growth and Increases Operating Margin; Reaffirms Fiscal Year 2018 Financial Outlook WATERTOWN, Mass., April 26, 2018 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ: ATHN ) (“ [...]

Pages